Compounded semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Whats your approach to increasing the dose and handling side effects
This helps the body manage blood sugar levels more effectively
Those who suspect thyroid dysfunction, based on family history or undiagnosed symptoms, can also benefit greatly by undergoing advanced diagnostics and early intervention strategies
This allows your provider to determine whether GLP-1 therapy may be appropriate based on your individual goals and health status
Tirzepatide has a different mechanism and higher potency